Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Editorial Commentary: When should the patient with an inherited cardiac disease have an ICD?

Research output: Contribution to journalEditorialResearchpeer-review

  1. Symptoms and healthcare contact preceding sudden cardiac death in persons aged 1-49 years

    Research output: Contribution to journalReviewResearchpeer-review

  2. An overview of current and emerging devices for percutaneous left atrial appendage closure

    Research output: Contribution to journalReviewResearchpeer-review

  3. β-Adrenergic regulation of the cardiac Na+-K+ ATPase mediated by oxidative signaling

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Glucagon-like peptide 1--a cardiologic dimension

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Witnessed and unwitnessed sudden cardiac death: a nationwide study of persons aged 1-35 years

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Cardiac arrhythmias in patients hospitalized with COVID-19: The ACOVID study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Natural History and Clinical Characteristics of the First 10 Danish Families With Familial ST-Depression Syndrome

    Research output: Contribution to journalLetterResearchpeer-review

  4. Detection of atrial fibrillation with implantable loop recorders in horses

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Familial Evaluation in Idiopathic Ventricular Fibrillation: Diagnostic Yield and Significance of J-Wave Syndromes

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The implantable cardioverter defibrillator (ICD) is often considered a routine intervention for an inherited heart rhythm disorder (IHRD) despite there being little to no randomized data for non-ischemic indications. Furthermore, existing IHRD studies often do not report adverse ICD outcomes, and observational data increasingly show that complications are under-recognized. Only recently have tools emerged to address the rational use of ICDs for specific forms of IHRD, although the acceptable risk of device complications remains unestablished. Here, we summarize the evidence of ICD benefit and harm in IHRD, highlight current knowledge gaps, and propose alternative and adjunctive options to the transvenous ICD.

Original languageEnglish
JournalTrends in Cardiovascular Medicine
Volume30
Issue number7
Pages (from-to)422-423
Number of pages2
ISSN1050-1738
DOIs
Publication statusPublished - Oct 2020

    Research areas

  • Arrhythmogenic right ventricular cardiomyopathy, Brugada syndrome, Implantable cardioverter defibrillator, Inherited arrhythmia, Long qt syndrome

ID: 59483929